Character
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1000 Marina Blvd, Brisbane, California, ...Phone Number
(888) 295-7659Website
www.characterbio.comRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Character
Character Bio is a precision medicine and biotechnology company focused on developing targeted therapies for progressive polygenic diseases, with an initial emphasis on ophthalmology. The company integrates human genetics, longitudinal clinical data, medical imaging, and artificial intelligence to identify the biological and genetic drivers behind differences in disease progression. Its research focuses on conditions such as age-related macular degeneration and glaucoma, with the goal of identifying genetically defined patient subtypes and developing more precise treatments. Character Bio combines genomics, clinical research, machine learning, biomarker analysis, and drug discovery to create a patient-focused therapeutics platform.Explore more
Character Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Character your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Character has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Character has new funding data
Click to see if Character had a recent Job posting/layoffs
Check out if Character is spiking on competitors!
Character, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Character
Earning: See what the market has to say on Character recently announced quarterly report
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Character launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Character as Masked Content
Find 3 more new buyers
Compare Similar Companies to Character
Compare insights from companies similar to Character, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Character financials insights
Gather financial insights about Character, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Other Financing Round
$18M
2025
Series B
$110M
Stock/Share Issuance
$8.9M
Character Tech Stack
A closer look at the technologies used by Character
Most Recent Scoops
Open Position
Open Position
Open Position
Open Position
Open Position
Character News & Media
Character Biosciences Raises $93M in Series B Funding - FinSMEs
Character Biosciences, a Jersey City, N.J.-based precision medicine company improving drug development for polygenic diseases, raised $93M in Series B fundingMacular degeneration focused firm eyes the clinic after series B - C&EN
Character Biosciences raises $93 million to advance its peptide-based eye disease treatmentsCharacter Biosciences Announces Collaboration with Bausch + Lomb to Transform Ophthalmology with Precision Medicine
JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a pioneer in genetics-guided drug discovery and development, today announced a collaboration with Bausch + Lomb, a leading global eye health company, to develop innovative treatments for patients with age-related macular degeneration (AMD). This relationship, initiated in 2024, represents a major step forward by bringing together Bausch + Lomb's extensive expertise in ophthalmology with Character Bio’s integrated patient data platform aCharacter Biosciences Strengthens Leadership Team with Appointment of Laura Carter, Ph.D. as Chief Scientific Officer
SAN FRANCISCO--(BUSINESS WIRE)--Character Biosciences, a drug discovery and development company leveraging human genetics and medical imaging-based machine learning to target disease progression, today announced the appointment of Laura Carter, Ph.D. as Chief Scientific Officer. Dr. Carter brings a track record of more than 20 years of scientific leadership and expertise to Character, spanning target ID/validation through late stage clinical development across multiple therapeutic areas. “We ar
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Character
Sign Up For FreeTo access detailed company insights
Character Bio is a precision medicine and biotechnology company focused on developing targeted therapies for progressive polygenic diseases, with an initial emphasis on ophthalmology. The company integrates human genetics, longitudinal clinical data, medical imaging, and artificial intelligence to identify the biological and genetic drivers behind... Read More
